CookiesThis site uses cookies to analyze site interaction in order to improve the quality of service and ensure smooth operation of the site. In more detail in Cookies policy

A specialized edition intended for medical institutions and doctors.

Dexamethasone-Darnitsa

Corticosteroids for systemic use. Glucocorticoids. Dexamethasone

Release forms:

Solution for injections
Eye drops

Dexamethasone should be administered intravenously or intramuscularly in urgent cases and when oral administration is impossible in:

Diseases of the endocrine system
Rheumatic diseases (as an adjuvant therapy in the period when the main therapy did not work, that is, in patients in whom the analgesic and anti-inflammatory effects of non-steroidal anti-inflammatory drugs were unsatisfactory)
Skin diseases
Allergic diseases (not curable by traditional treatment)
Eye diseases
Gastrointestinal diseases
Diseases of the respiratory tract
Hematological diseases
Kidney diseases
Malignant oncological diseases
Edema of the brain
Shock
COVID-19

Characteristics of the productу:

Release formInjectable solution
ChildrenWith caution
PregnantWith caution
NursingContraindicated
Release categoryPrescription medication
AllergicsAllowed
DiabeticsWith caution
Temperature storage conditionsNot higher than 15 °С
Qualitative and quantitative composition:
Pharmaceutical form
Pharmacotherapeutic group
Pharmacological properties.
Clinical particulars
Therapeutic indications.
Contraindications.
Interaction with other medicinal products and other forms of interaction
Special warnings and precautions for use.
Posology and method of administration.
Overdose.
Undesirable effects
Shelf life.
Special precautions for storage
Incompatibilities.
Nature and contents of container
Category of release
Manufacturer
The manufacturer's location and address of the place of business
Date of last revision